CBUSNasdaqAgricultural ChemicalsFiscal year ends December 31
Cibus, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.31−0.01 (-0.76%)
Close on Oct 19, 2026
- Market cap
- $100.55M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
24.2%
19M of 76M shares
Institutional holders
62
13 new, 17 sold out
Net institutional buying
-3M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| FMR LLC | 7,319,174 | 13.90% | 13G (passive) amendment | Dec 31, 2025 |
| Armistice Capital, LLC | 1,948,000 | 5.97% | 13G (passive) | Mar 31, 2025 |
| Rory B. Riggs | 18,726,128 | 33.02% | 13D (active) amendment | Sep 18, 2024 |
| Abigail P. Johnson | 11,425,929 | 15.00% | 13G (passive) amendment | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CBUS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 11,449,660 | 14.98% | $15.69M | +23,731 | 0.00% |
| Vanguard Capital Management LLC | 2,299,966 | 3.01% | $3.15M | +181,470 | 0.00% |
| United Capital Financial Advisers, LLC | 576,043 | 0.75% | $789.18K | – | 0.00% |
| Geode Capital Management, LLC | 528,233 | 0.69% | $723.91K | +45,324 | 0.00% |
| BlackRock, Inc. | 492,795 | 0.64% | $675.13K | +77,619 | 0.00% |
| Certior Financial Group, LLC | 337,710 | 0.44% | $462.66K | +19,507 | 0.25% |
| Prescott Group Capital Management, L.L.C. | 328,157 | 0.43% | $449.58K | – | 0.04% |
| Squarepoint Ops LLC | 312,340 | 0.41% | $427.91K | +237 | 0.00% |
| Vanguard Fiduciary Trust Co | 310,136 | 0.41% | $424.89K | +51,988 | 0.00% |
| Corient Private Wealth LLC | 164,974 | 0.22% | $226.02K | – | 0.00% |
| State Street Corp | 157,189 | 0.21% | $215.35K | – | 0.00% |
| LPL Financial LLC | 142,431 | 0.19% | $195.13K | +37,138 | 0.00% |
| Renaissance Technologies LLC | 132,500 | 0.17% | $181.53K | +33,600 | 0.00% |
| Northern Trust Corp | 130,935 | 0.17% | $179.38K | +26,224 | 0.00% |
| Capital Advisor Network LLC | 129,975 | 0.17% | $178.07K | +52,351 | 0.22% |
| Lynx Capital Group Ltd /Adv | 74,000 | 0.10% | $101.38K | +20,000 | 0.04% |
| Summit Trail Advisors, LLC | 69,114 | 0.09% | $94.69K | – | 0.00% |
| Citigroup Inc | 63,564 | 0.08% | $87.08K | +50,291 | 0.00% |
| Moneta Group Investment Advisors LLC | 59,474 | 0.08% | $81.48K | New | 0.00% |
| Millennium Management LLC | 59,004 | 0.08% | $80.84K | −366,038 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 62 | 19M | 24.2% | 13 / 18 | 12 / 17 | 1M | 4M |
| Q1 2026 | 66 | 22M | 28.7% | 30 / 22 | 6 / 12 | 13M | 0M |
| Q4 2025 | 51 | 12M | 15.9% | 11 / 13 | 14 / 12 | 1M | 0M |
| Q3 2025 | 53 | 11M | 15.0% | 7 / 9 | 19 / 15 | 0M | 2M |
| Q2 2025 | 61 | 13M | 16.6% | 17 / 14 | 17 / 24 | 4M | 4M |
| Q1 2025 | 69 | 12M | 15.8% | 9 / 24 | 15 / 10 | 3M | 0M |
| Q4 2024 | 71 | 10M | 12.4% | 21 / 28 | 10 / 8 | 1M | 0M |
| Q3 2024 | 60 | 9M | 11.7% | 16 / 22 | 5 / 12 | 2M | 1M |
| Q2 2024 | 57 | 8M | 10.9% | 21 / 18 | 8 / 15 | 3M | 1M |
| Q1 2024 | 51 | 6M | 8.2% | 19 / 15 | 6 / 3 | 1M | 0M |
| Q4 2023 | 35 | 6M | 7.4% | 11 / 13 | 4 / 7 | 1M | 0M |
| Q3 2023 | 31 | 5M | 6.2% | 13 / 6 | 4 / 8 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CBUS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Growth Company Fund | 3,403,624 | 4.45% | $4.90M | 0.00% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 1,602,469 | 2.10% | $2.20M | 0.00% | Jun 30, 2026 |
| Fidelity Growth Company K6 Fund | 974,876 | 1.28% | $1.40M | 0.01% | May 31, 2026 |
| Fidelity Series Growth Company Fund | 848,828 | 1.11% | $1.22M | 0.00% | May 31, 2026 |
| Fidelity Blue Chip Growth Fund | 713,362 | 0.93% | $1.38M | 0.00% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 637,314 | 0.83% | $873.12K | 0.00% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 196,886 | 0.26% | $269.73K | 0.02% | Jun 30, 2026 |
| Fidelity Series Blue Chip Growth Fund | 133,771 | 0.18% | $258.18K | 0.00% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 131,371 | 0.17% | $189.17K | 0.00% | May 31, 2026 |
| Fidelity Blue Chip Growth K6 Fund | 120,908 | 0.16% | $233.35K | 0.00% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 61,483 | 0.08% | $88.54K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 59,962 | 0.08% | $86.35K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 43,620 | 0.06% | $62.81K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 30,652 | 0.04% | $41.99K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 29,531 | 0.04% | $40.46K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Craig Wichner | CEO | 894,309 | 1.17% | Jun 10, 2026 |
| Peter Beetham | Interim CEO, Pres & COO | 686,825 | 0.90% | Apr 28, 2026 |
| Gregory Francis William Gocal | Chief Scientific Officer & EVP | 422,890 | 0.55% | Apr 28, 2026 |
| Carlo Broos | CFO | 228,472 | 0.30% | Apr 28, 2026 |
| Jason Stokes | CAO, Gen Csl & Corp Secy | 167,865 | 0.22% | Apr 28, 2026 |
| Noel Sauer | Sr VP, Research | 139,879 | 0.18% | Apr 28, 2026 |
| Rory B. Riggs | Director | 14,982,312 | 19.60% | Jun 4, 2026 |
| Kimberly Ann Box | Director | 0 | – | Jun 4, 2026 |
| August J. Moretti | Director | 0 | – | Jun 4, 2026 |
| Mark Terrence Finn | Director | 2,951,382 | 3.86% | Jun 4, 2026 |
| Jean-Pierre Jules Lehmann | Director | 2,450,975 | 3.21% | Jun 4, 2026 |
| Gerhard Prante | Director | 104,945 | 0.14% | Jun 4, 2026 |
| Thomas Urban | Director | 64,748 | 0.08% | Jun 4, 2026 |
| Keith Allen Walker | Director | 98,701 | 0.13% | May 27, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Craig Wichner CEO | Jun 8, 2026 | Award | +894,309 | – | – | 894,309 |
| Gerhard Prante Director | Jun 2, 2026 | Award | +64,748 | – | – | 104,945 |
| Thomas Urban Director | Jun 2, 2026 | Award | +64,748 | – | – | 64,748 |
| Jean-Pierre Jules Lehmann Director | Jun 2, 2026 | Award | +64,748 | – | – | 763,904 |
| Gregory Francis William Gocal Chief Scientific Officer & EVP | Apr 24, 2026 | Award | +57,000 | – | – | 422,890 |
| Carlo Broos CFO | Apr 24, 2026 | Award | +57,000 | – | – | 154,275 |
| Peter Beetham Interim CEO, Pres & COO | Apr 24, 2026 | Award | +195,000 | – | – | 686,825 |
| Jason Stokes CAO, Gen Csl & Corp Secy | Apr 24, 2026 | Award | +57,000 | – | – | 167,865 |
| Carlo Broos CFO | Apr 24, 2026 | Award | +57,000 | – | – | 154,275 |
| Noel Sauer Sr VP, Research | Apr 24, 2026 | Award | +38,000 | – | – | 139,879 |
| Jason Stokes CLO, Gen Csl & Secy | Mar 30, 2026 | Tax withholding | −3,695 | $1.83 | $6.76K | 110,865 |
| Carlo Broos CFO | Mar 30, 2026 | Tax withholding | −3,676 | $1.87 | $6.87K | 97,275 |
| Peter Beetham Interim CEO, Pres & COO, Director | Mar 30, 2026 | Tax withholding | −16,112 | $1.85 | $29.81K | 491,825 |
| Noel Sauer Sr VP, Research | Mar 30, 2026 | Tax withholding | −1,763 | $1.84 | $3.24K | 101,879 |
| Gregory Francis William Gocal Chief Scientific Officer & EVP | Mar 30, 2026 | Tax withholding | −8,954 | $1.82 | $16.30K | 365,890 |
| Jason Stokes CLO, Gen Csl & Secy | Feb 19, 2026 | Tax withholding | −4,795 | $2.98 | $14.29K | 114,560 |
| Jean-Pierre Jules Lehmann Director | Jan 29, 2026 | Award | +666,666 | $1.50 | $1,000.00K | 699,156 |
| Rory B. Riggs Director, 10% owner | Jan 29, 2026 | Award | +333,333 | $1.50 | $500.00K | 14,916,640 |
| Carlo Broos CFO | Nov 11, 2025 | Tax withholding | −1,496 | $1.32 | $1.97K | 100,951 |
| Noel Sauer Sr VP, Research | Nov 11, 2025 | Tax withholding | −1,834 | $1.32 | $2.42K | 103,642 |
| Jason Stokes CLO, Gen Csl & Secy | Nov 11, 2025 | Tax withholding | −3,519 | $1.32 | $4.65K | 119,355 |
| Noel Sauer Sr VP, Research | Jun 13, 2025 | Sale | −4 | $1.49 | $6 | 105,476 |
| Rory B. Riggs Director, 10% owner | Jun 9, 2025 | Option exercise | +50,000 | $0.01 | $500 | 14,583,307 |
| Rory B. Riggs Director, 10% owner | Jun 9, 2025 | Option exercise | +4,000,000 | – | – | 14,533,307 |
| Rory B. Riggs Director, 10% owner | Jun 5, 2025 | Award | +5,714,286 | $1.75 | $10.00M | 10,533,307 |
| Gerhard Prante Director | May 22, 2025 | Award | +32,490 | – | – | 40,197 |
| Jean-Pierre Jules Lehmann Director | May 22, 2025 | Award | +32,490 | – | – | 32,490 |
| Jason Stokes CLO, Gen Csl & Secy | Mar 24, 2025 | Award | +28,250 | – | – | 127,669 |
| Noel Sauer SVP, Research | Mar 24, 2025 | Award | +11,750 | – | – | 105,480 |
| Gregory Francis William Gocal Chief Scientific Officer & EVP | Mar 24, 2025 | Award | +60,000 | – | – | 374,844 |
| Carlo Broos Interim CFO | Mar 24, 2025 | Award | +28,250 | – | – | 102,447 |
| Peter Beetham President and COO, Director | Mar 24, 2025 | Award | +125,500 | – | – | 507,937 |
| Gerhard Prante Director | Feb 25, 2025 | Sale(10b5-1 plan) | −1,150 | $1.92 | $2.21K | 7,707 |
| Gerhard Prante Director | Feb 24, 2025 | Sale(10b5-1 plan) | −1,150 | $2.07 | $2.38K | 8,857 |
| Gerhard Prante Director | Feb 21, 2025 | Sale(10b5-1 plan) | −1,150 | $2.20 | $2.53K | 10,007 |
| Gerhard Prante Director | Feb 20, 2025 | Sale(10b5-1 plan) | −1,150 | $2.35 | $2.70K | 11,157 |
| Jason Stokes CLO, Gen Csl & Secy | Feb 19, 2025 | Tax withholding | −4,795 | $2.33 | $11.17K | 122,874 |
| Gerhard Prante Director | Feb 19, 2025 | Sale(10b5-1 plan) | −1,150 | $2.58 | $2.97K | 12,307 |
| Gerhard Prante Director | Feb 18, 2025 | Sale(10b5-1 plan) | −1,150 | $2.52 | $2.90K | 14,607 |
| Gerhard Prante Director | Feb 18, 2025 | Sale(10b5-1 plan) | −1,150 | $2.52 | $2.90K | 13,457 |
| Gerhard Prante Director | Feb 14, 2025 | Sale(10b5-1 plan) | −1,150 | $2.60 | $2.99K | 15,757 |
| Gerhard Prante Director | Feb 13, 2025 | Sale(10b5-1 plan) | −1,150 | $2.53 | $2.91K | 16,907 |
| Gerhard Prante Director | Feb 12, 2025 | Sale(10b5-1 plan) | −1,150 | $2.45 | $2.82K | 18,057 |
| Gerhard Prante Director | Feb 11, 2025 | Sale(10b5-1 plan) | −1,150 | $2.48 | $2.85K | 19,207 |
| Gerhard Prante Director | Feb 10, 2025 | Sale(10b5-1 plan) | −1,150 | $2.52 | $2.90K | 20,357 |
| Gerhard Prante Director | Feb 7, 2025 | Sale(10b5-1 plan) | −1,150 | $2.50 | $2.88K | 21,507 |
| Gerhard Prante Director | Feb 6, 2025 | Sale(10b5-1 plan) | −1,150 | $2.55 | $2.93K | 22,657 |
| Gerhard Prante Director | Feb 5, 2025 | Sale(10b5-1 plan) | −1,150 | $2.52 | $2.90K | 23,807 |
| Gerhard Prante Director | Feb 4, 2025 | Sale(10b5-1 plan) | −1,150 | $2.45 | $2.82K | 24,957 |
| Gerhard Prante Director | Feb 3, 2025 | Sale(10b5-1 plan) | −1,150 | $2.41 | $2.77K | 26,107 |
| Gerhard Prante Director | Jan 31, 2025 | Sale(10b5-1 plan) | −1,150 | $2.55 | $2.93K | 27,257 |
| Gerhard Prante Director | Jan 30, 2025 | Sale(10b5-1 plan) | −1,150 | $2.46 | $2.83K | 28,407 |
| Gerhard Prante Director | Jan 29, 2025 | Sale(10b5-1 plan) | −1,150 | $2.42 | $2.78K | 29,557 |
| Gerhard Prante Director | Jan 28, 2025 | Sale(10b5-1 plan) | −1,150 | $2.44 | $2.81K | 30,707 |
| Gerhard Prante Director | Jan 27, 2025 | Sale(10b5-1 plan) | −1,150 | $2.37 | $2.73K | 31,857 |
| Gerhard Prante Director | Jan 24, 2025 | Sale(10b5-1 plan) | −1,150 | $2.60 | $2.99K | 33,007 |
| Gerhard Prante Director | Jan 23, 2025 | Sale(10b5-1 plan) | −1,150 | $2.59 | $2.98K | 34,157 |
| Gerhard Prante Director | Jan 22, 2025 | Sale(10b5-1 plan) | −1,150 | $2.31 | $2.66K | 35,307 |
| Gerhard Prante Director | Jan 21, 2025 | Sale(10b5-1 plan) | −1,150 | $2.50 | $2.88K | 36,457 |
| Gerhard Prante Director | Jan 21, 2025 | Sale(10b5-1 plan) | −1,150 | $2.50 | $2.88K | 37,607 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Gerhard Prante Director | Nov 18, 2024 | 71,785 | $343.13K | Nov 18, 2024 | Received as consideration in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated 1/13/2023 (as amended), by and among the Issuer, Calypso Merger Sub |
| Gocal Greg Officer | Jun 27, 2024 | 18,000 | $163.08K | Jun 27, 2024 | Restricted Stock Units |